Intranasal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection - Mallett,C.P.; Hale,T.L.; Kaminski,R.W. (Infect Immun, 1995)